NANO Nuclear Energy heads into its August 14 earnings report as one of the most aggressively shorted names in the small-cap nuclear space — and the borrow market confirms bears have nearly exhausted their ammunition.
Short interest is the dominant signal here. Nearly 30% of NNE's free float is now sold short, a figure that climbed another 14% in a single session on August 11 and is up roughly 11% on the week. The ORTEX short score hit 75.6 — its highest reading in the tracked window — underscoring how heavily-positioned the bear side has become. Yet the borrow market tells a simultaneously cautionary tale for new shorts: availability has collapsed to just 1.3% of shares outstanding relative to short interest, meaning the lending pool is virtually tapped out. The 52-week low hit zero. Cost to borrow, at 1.96%, has ticked up 16% over the past week but remains a modest absolute level — it does not yet represent a prohibitive squeeze, but the structural tightness is real. With 7.1 days to cover per FINRA's most recent settlement data, any sustained buying pressure concentrates meaningful covering risk.
The bull-bear divide is unusually wide going into the print. Analysts who have initiated coverage recently are split: Alliance Global Partners started NNE at Buy with a $46 target in late July, and Roth Capital came in at Buy with $45 in June, both seeing the micro-cap nuclear theme as substantially undervalued relative to the current $19 level. Truist, by contrast, initiated at Hold with a $22 target — barely above the current price — essentially flagging that the speculative premium is difficult to justify against near-term fundamentals. The valuation picture reflects that tension: the company carries a negative P/E and a deeply negative EV/EBITDA, meaning the investment case is almost entirely thesis-driven rather than earnings-supported. The analyst recommendation differential factor ranks in the 93rd percentile, suggesting growing coverage optimism, but that optimism is clearly not unanimous.
Institutional flows add nuance to the setup. BlackRock added roughly 573,000 shares in July, and Van Eck picked up another 729,000 — meaningful accumulation relative to the company's size. The top holder, I Financial Ventures Group, trimmed 500,000 shares in the same period. On the insider side, the CEO sold roughly $694,000 worth of stock in early June, alongside the CFO, CTO, and the principal private equity backer — a cluster of insider selling that bears have been happy to cite. At the last print in May, the stock fell nearly 8% on the day and shed another 7% over the following five sessions, setting a precedent that the market has not been forgiving on results day.
Options traders are notably relaxed about the setup by comparison. The put/call ratio at 0.52 sits just below its 20-day average and well south of its 52-week high of 0.80, suggesting the options market is not pricing in unusual downside risk relative to recent norms. That divergence — a near-fully-tapped borrow market on one side and a calm options skew on the other — makes Thursday's print a direct test of whether a pre-revenue nuclear developer can give short sellers a fundamental reason to stay put, or hand the crowded long side a catalyst to press the squeeze.
See the live data behind this article on ORTEX.
Open NNE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
